Hypoxia Inducible Factor 2a (Hypoxia Inducible Factor 2 alpha, Hypoxia Inducible Factor 2 alpha Subunit, HIF-2a, Endothelial PAS Domain Containing Protein 1, Endothelial Pas Domain Protein 1, EPAS1, EPAS-1, HIF-2 alpha, HIF2a, HIF1 alpha-like Factor, HLF,

Size

100ul

Hosts

Rabbit

Form

Supplied as a liquid in Tris-glycine, pH 7.5, 150mM sodium chloride, 0.05% sodium azide.

Purity

Purified by immunoaffinity chromatography.

References

1. Alvarez-Tejado, M., et al. Journal of Biological Chemistry. 276(25): 22368-22374, 2001. 2. Alvarez-Tejado, M., et al. Journal of Biological Chemistry. 277(16): 13508-13517, 2002. 3. Asikainen, T.M., et al. PNAS. 102(29): 10212-10217, 2005. (Western blot, human) 4. Baba, M., et al. Oncogene. 22: 2728-2738, 2003. 5. Bernaudin, M., et al. Brain Genomic Response Following Hypoxia and Re-oxygenation in the Neonatal Rat: Identification of Genes That Might Contribute to Hypoxia-Induced Ischemic Tolerance. JBC Papers in Press. Published on July 26, 2002 as manuscript M204619200. 6. Biju, M., et al. V Mol. Cell. Biol 24: 9038-9047, 2004. 7. Block, K., et al. (2007) NAD(P)H Oxidases Regulate HIF-2{alpha} Protein Expression, 282, 8019-8026. 8. Bonicalzi, M., et al. Role of Exon 2-encoded beta-Domain of the von Hippel-Lindau Tumor Suppressor Protein. The Journal of Biological Chemistry. 276(2):1407-1416, 2001. 9. Bracken, et al. (2006) Stabilization and Transactivation in a Graded Oxygen Environment, 281, 22575-22585. 10. Burke, B., et al. Journal of Pathology. 196: 204-212, 2002. \n11. Calvani, M., et al. (2006) 107: 2705-2712. 12. Carroll, P. A., et al. (2006) 80: 10802-10812. 13. Chan, D., et al. Journal of Biological Chemistry. 277(42): 40112-40117, 2002.\n14. Chavez, J. C., et al. (2006) The Transcriptional Activator Hypoxia Inducible Factor 2 (HIF-2/EPAS-1) Regulates the Oxygen-Dependent Expression of Erythropoietin in Cortical Astrocytes, 26, 9471-9481.15. Conrad, P., et al Journal of Biological Chemistry. 274(47): 33709-33713, 1999. 16. Corn, P., et al.. Nature Genetics. 35: 229-237, 2003.17. Cuevas, Y., et al. Specific Oncolytic Effect of a New Hypoxia-Inducible Factor-Dependent Replicative Adenovirus on von Hippel-Lindau-Defective Renal Cell Carcinomas. Cancer Research 63, 6877-6884, October 15, 2003.\n18. de Paulsen, N., et al. Role of transforming growth factor-alpha in Von Hippel-Lindau (VHL)-/- clear cell renal carcinoma cell proliferation: A possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis. PNAS. 98(4): 1387-1392, 2001. (flow cytometry, western blot, human) \n19. Evans, A. J., et al. (2007) VHL Promotes E2 Box-Dependent E-Cadherin Transcription by HIF-Mediated Regulation of SIP1 and Snail, 27, 157-169.\n20. Franovic, A., et al. (2006) Multiple Acquired Renal Carcinoma Tumor Capabilities Abolished upon Silencing of ADAM17, 66, 8083-8090.\n21. Freeburg, P., et al. Divergent Expression Patterns for Hypoxia-Inducible Factor-1beta and Aryl Hydrocarbon Receptor Nuclear Transporter-2 in Developing Kidney. J. Am. Soc. Nephrol. 15: 2569-2578, 2004.\n22. Grabmaier, K., et al. Strict regulation of CAIXG250/MN by HIF-1 alpha in clear cell renal cell carcinoma. Oncogene.\n23. Graven,K., et al. HIF-2 alpha glyceraldehyde-3-phosphate dehydrogenase expression in endothelial cells. Biochimica et Biophysica ACTA. 93794:1-9, 2003.\n24. Grover, T. R., et al. (2007) Hypoxia inducible factors HIF- 1alpha and HIF-2alpha are decreased in an experimental model of severe respiratory distress syndrome in preterm lambs, 00372.02006.\n25. Gruber, M., et al. Acute postatal ablation of HIF-2 alpha results in anemia. PNAS 2007; 104; 2301-2306.\n26. Haase, V.H., et al. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. PNAS. 98(4): 1583-1588, 2001. \n27. Hergovich, A., et al. (2006) Priming-Dependent Phosphorylation and Regulation of the Tumor Suppressor pVHL by Glycogen Synthase Kinase 3, 26, 5784-5796.\n28. Hu, C-J., et al. Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1) and HIF-2 in stem cells. Mol. Cell Biol. 26:3514-3526, 2006.\n29. Hui, A. S., et al. (2006) Calcium signaling stimulates translation of HIF-{alpha} during hypoxia, 20, 466-475.\n30. Ietta, F., et al. Dynamic HIF-1alpha regulation during human placental development. Biol. Reprod. 2006. 75, 112-121.\n31. Khatua, S., et al. Overexpression of the EGFR/FKBP12/HIF-2alpha Pathway Identified in Childhood Astrocytomas by Angiogensis Gene Profiling. Cancer Research.63:1865-1870, 2003.\n32. Koizume, S., et al. (2006) Activation of Cancer Cell Migration and Invasion by Ectopic Synthesis of Coagulation Factor VII, 66, 9453-9460.\n33. Kojima, I., Tet al. (2007) Protective Role of Hypoxia-Inducible Factor-2{alpha} against Ischemic Damage and Oxidative Stress in the Kidney, ASN.2006060639.\n34. Kondo, K., et al. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell. 1: 237-246, 2002.\n35. Krishnamachary, B., et al. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor supporessor-null renal cell carcinoma mediated by TCF3, ZFHX1A and ZFHX1B. Cancer Res. 66:2725-2731, 2006.\n36. Kurban, G., et al. Characterization of a von Hippel Lindau Pathway Involved in Extracellular Matrix Remodeling, Cell Invasion, and Angiogenesis. Cancer Res 2006; 66: (3), 2006.\n37. Liang, Y., et al. Activation of Vascular Endothelial Growth Factor A Transcription in Tumorigenic glioblastoma Cell Lines by an Enhancer with Cell Type-specific Dnase I Accessibility. Journal of Biological Chemistry. 277(22): 20087-20094, 2002.\n38. Lin, Q., Lee, Y.-J., and Yun, Z. (2006) Differentiation Arrest by Hypoxia, 281, 30678-30683.\n39. Luo, J.C., et al. A variant of nuclear localization signal of bipartite-type is required for the nuclear translocation of hypoxia inducible factors (1alpha, 2alpha and 3alpha). Oncogene. 20: 1435-1444, 2001.\n40. Lutz, M. S., and Burk, R. D. (2006) Primary Cilium Formation Requires von Hippel-Lindau Gene Function in Renal-Derived Cells, 66, 6903-6907.\n41. Mabjeesh, N, et al. Androgens Stimulate Hypoxia-inducible Factor 1 Activation via Autocrine Loop of Tyrosine Kinase Receptor/Phosphatidylinositol 3-Kinase /Protein Kinase B in Prostate Cancer Cells. Clinical Cancer Research: Vol. 9, 2416-2425, July 2003. \n42. Mabjeesh, N., et al. 2ME2 inhibits tumor growth and angiog1enesis by disrupting microtubules and dysregulating HIF. Cancer Cell. 3:363-375,2003.\n43. Mack, F., et al. Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but dose not promote tumor growth. Cancer Cell. 3:75-88, 2003.\n44. MacKenzie, E. D., et al. (2007) Cell permeating {alpha}-ketoglutarate derivatives alleviate pseudo-hypoxia in SDH deficient cells, MCB.01927-01906.\n45. Makino, Y., et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature. 414: 550-554, 2001. \n46. Maranchie, J., et al. The contribution of VHL substrate binding and HIF-1alpha to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell. 1: 247-255, 2002. \n47. Martin-Puig, S., et al. Role of Iron (II)-2-Oxogluterate-dependent Dioxygenases in the Generation of Hypoxia-induced Phosphatidic Acid through HIF-1/2 and von Hippel-Lindau-independent Mechanisms. J. Biol. Chem. 279: 9504-9511, 2004.\n48. Mekhail, K., et al. HIF activation by pH-dependent nucleolar sequestration of VHL. Nature Cell Biology.\n49. Michenko, A., et al. Hypoxia-inducible factor-1 (HIF-1) mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-biophosphatase-3 (PFKBF3) gene: its possible role in the Warburg effect. JBC Papers in Press. 277(8): 6183-6187, 2002.\n50. Miller, F., et al. Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL: HIF-1alpha complex. J. Biol. Chem. 280(9): 7985-7996, 2005. \n51. Mizukami, Y., et al. Hypoxia-Inducible Factor-1-Independent Regulation of Vascular Endothelial Growth Factor by Hypoxia in Colon Cancer. Cancer Research. 64:1765-1772, March 1, 2004.\n52. Mizukami, Y., et al. (2006) Hypoxic Regulation of Vascular Endothelial Growth Factor through the Induction of Phosphatidylinositol 3-Kinase/Rho/ROCK and c-Myc, 281, 13957-13963.\n53. Mohan, S., et al. von Hippel-Linau protein complex is regulated by cell density. Oncogene. 22: 5270-5280, 2003.\n54. Nakamura, K., et al. (2006) Brain-Derived Neurotrophic Factor Activation of TrkB Induces Vascular Endothelial Growth Factor Expression via Hypoxia-Inducible Factor-1{alpha} in Neuroblastoma Cells, 66, 4249-4255.\n55. Naranjo-Suarez, S., et al. Down-regulation of Hypoxia-inducible Factor-2 in PC12 Cells by Nerve Growth Factor Stimulation. Journal of Biological Chemistry. 278(34): 31895-31901, 2003.\n56. Niv, A., et al. Histologic Artrial Myolysis Is Associated With Atrial Fibrillation Cardiac Operation. The Society of Thoracic Surgeons. 72: 688-93, 2001.\n57. Ohh, M., et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the Beta-domain of the von Hippel- Lindau protein. Nature Cell Biology. 2(7): 423-427, 2000. \n58. Okuyama, H., et al. (2006) Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1, 281, 15554-15563.\n59. Palayoor, S., et al. Ibuprofen-mediated Reduction of Hypoxia-inducible Factors HIF-1 alpha and HIF-2 alpha in Prostate Cancer Cells. Clinical Cancer Research. 9:3150-3157, 2003.\n60. Pan, Y., et al. p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment. Oncogene.\n61. Park, S, et al. Hypoxia-Induced Gene Expression Occurs Solely through the Action of Hypoxia-Inducible Factor 1 alpha (HIF-1 alpha): Role of Cytoplasmic Trapping of HIF-2 alpha: Molecular and Cellular Biology, July 2003, p. 4959-4971.\n62. Peso, L., et al. The von Hippel Lindau/Hypoxia-inducible Factor (HIF) Pathway Regulates the Transcription of the HIF-Proline Hydroxylase Genes in Response to Low Oxygen. Journal of Biological Chemistry. 278(49):48690-48695, 2003.\n63. Rajakumar, A., and Conrad, K. Expression, Ontogeny, and Regulation of Hypoxia-Inducible Transcription Factors in the Human Placenta. Biology of Reproduction. 63: 559-569, 2000. \n64. Rathmell, W., et al. In Vitro and In Vivo Models Analyzing von Hippel-Lindau Disease-Specific Mutations. Cancer Research. 64: 8595-8603, 2004.\n65. Sato, M., et al. The PAI-1 Gene as a Direct Target of Endothelial PAS Domain Protein-1 in Adenocarcinoma A549 Cells. Am. J. Respir. Cell Mol. Biol. 31: 209-215, 2004.\n66. Schultz, K., Fanburg, B. L., and Beasley, D. (2006) Hypoxia and hypoxia-inducible factor-1{alpha} promote growth factor-induced proliferation of human vascular smooth muscle cells, 290, H2528-2534.\n67. Shinojima, T., et al. (2006) Renal cancer cells lacking hypoxia inducible factor (HIF)-1{alpha} expression maintain vascular endothelial growth factor expression through HIF-2{alpha}, bgl143.\n68. Smith, K., et al. Silencing of Epidermal Growth Factor Receptor Suppresses Hypoxia-Inducible Factor-2-Driven VHL-I- Renal Cancer. Cancer Res 2005; 65: (12), 2005.\n69. Staller, P., et al. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumor suppressor pVHL. Letters to Nature. 425(18): 307-311. \n70. Takeda, K., et al. (2006) Placental but Not Heart Defects Are Associated with Elevated Hypoxia-Inducible Factor {alpha} Levels in Mice Lacking Prolyl Hydroxylase Domain Protein 2, 26, 8336-8346.\n71. Takeda, N., et al. Endothelial PAS Domain Protein 1 Gene Promotes Angiogenesis Through the Transactivation of Both Vascular Endothelial Growth Factor and Its Receptor, Flt-1. Circ. Res. 95: 146-153, 2004.\n72. Tang, N.,et al. Loss of HIF-1 alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell. 6:485-495, 2004. (Western Blot, Mouse).\n73. Temes, E., et al. Activation of HIF-prolyl hydroxylase by R59949, an inhibitor of the diacylglycerol kinase. J. Biol. Chem. 280(25): 24238-24244, 2005. (Western blot, human)\n74. Toro, R., et al. Induction of T-type Calcium Channel Gene Expression by Chronic Hypoxia. Journal of Biological Chemistry. 278(25): 22316-22324, 2003.\n75. Uchida, T., et al. Prolonged Hypoxia Differentially Regulates Hypoxia-inducible Factor (HIF)-1 alpha and HIF-2 alpha Expression in Lung Epithelial Cells: Implication of Natural Antisense HIF-1 alpha. Mechanisms of Signal Transduction. 279: 14871-14878, 2004.\n76. Welsh, S., et al. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha. Mol. Cancer Ther. 3: 233-244, 2004.\n77. Xia, G., et al. Positive expression of HIF-2 alpha / EPAS1 in invasive bladder cancer. Elsevier. 59(5):774-778,2002.\n78. Yuan, Y., et al. Cobalt Inhibits the Interaction between Hypoxia-inducible Factor-alpha and von Hippel-Lindau Protein by Direct Binding to Hypoxia-inducible Factor-alpha. Journal of Biological Chemistry. 278(18): 15911-15916, 2003.\n79. Zhang, H., et al. Cancer Cell 11. 407-420. May 2007.\n80. Zimmer, M., et al. Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/-tumors. Mol. Can. Res. 2:89-95, 2004. (Western blot, ELISA, human/mouse)\n81. Takeda, K., et al. Placental but Not Heart Defects Are Associated with Elevated Hypoxia-Inducible Factor {alpha} Levels in Mice Lacking Prolyl Hydroxylase Domain Protein 2. 26: 8336-8346, 2006.\n82. Koizume, Shiro., et al. Molecular Biology, Pathobiology, and Genetics: Activation of Cancer cell Migration and Invasion by Ectopic Synthesis fo Coagulation Factor VII. 66: 9453-9460, 2006.\n83. Nagano, M., et al. Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. Blood, Jul 2007; 110: 151 - 160.\n84. Milkiewicz, M., J. L. Doyle, et al. (2007). HIF-1{alpha} and HIF-2{alpha} play a central role in stretch-induced but not shear-stress-induced angiogenesis in rat skeletal muscle. 583: 753-766.